Tag Archives: CANF

Best Casino Stocks To Invest In Right Now

Last weekend I enjoyed a wonderful stay at the Mirage Hotel and Casino in Las Vegas, Nevada. Its right on the Vegas Strip, famous for its world-class casinos.

I wasnt there to gamble however.

My reason for being in Vegas was to see whats going on in the booming cannabis industry.

My goal was to attend the largest cannabis trade show of the year and find the next best moneymaking opportunities for you.

Believe me when I say it. Theres a ton of opportunity out there.

Marijuana is Big Business

Hundreds of exhibitors were on display.

I talked to a number of entrepreneurs and investors about the latest developments in this budding industry. All with a focus on finding the best investment opportunities.

Needless to say its been a lot of fun!

Whats really astonishing though is how big this industry has become.

Best Casino Stocks To Invest In Right Now: AcelRx Pharmaceuticals Inc.(ACRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Cemtrex, Inc. (NASDAQ: CETX) fell 7.1 percent to $2.10 in pre-market trading after rising 4.15 percent on Friday
    Bioblast Pharma Ltd. (NASDAQ: ORPN) fell 7.1 percent to $2.10 in pre-market trading after dipping 9.05 percent on Friday.
    LexinFintech Holdings Ltd. (NASDAQ: LX) fell 5.9 percent to $17.15 in pre-market trading after reporting Q1 results.
    AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares fell 5.1 percent to $2.80 in pre-market trading after dropping 1.67 percent on Friday.
    China Telecom Corporation Limited (NYSE: CHA) shares fell 4.1 percent to $45.70 in pre-market trading.
    Carver Bancorp, Inc. (NASDAQ: CARV) fell 4 percent to $8.00 in pre-market trading after tumbling 24.36 percent on Friday.
    Tuesday Morning Corporation (NASDAQ: TUES) shares fell 3.6 percent to $2.65 in pre-market trading.
    Cheetah Mobile Inc. (NYSE: CMCM) shares fell 3.4 percent to $11.90 in pre-market trading following Q1 results.
    Qudian Inc. (NYSE: QD) fell 3.3 percent to $11.10 in pre-market trading after reporting Q1 results.
    Fifth Third Bancorp (NASDAQ: FITB) fell 3.1 percent to $32.53 in pre-market trading after announcing plan to acquire MB Financial for $54.70 per share in cash and stock

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares climbed 154.95 percent to close at $5.15 on Thursday. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Tyme Technologies, Inc. (NASDAQ: TYME) jumped 33.45 percent to close at $3.87.
    Universal Corporation (NYSE: UVV) gained 29.72 percent to close at $62.85 after reporting fiscal Q4 results.
    Evolus, Inc. (NASDAQ: EOLS) shares rose 22.93 percent to close at $23.80.
    nLIGHT, Inc. (NASDAQ: LASR) jumped 21.52 percent to close at $36.37 following Q1 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) gained 20.28 percent to close at $2.61.
    The Cato Corporation (NYSE: CATO) shares rose 19.57 percent to close at $21.45 after the company posted better-than-expected first-quarter results.
    AXT, Inc. (NASDAQ: AXTI) gained 18.8 percent to close at $7.90.
    Catasys, Inc. (NASDAQ: CATS) rose 16.33 percent to close at $6.41.
    HUYA Inc. (NYSE: HUYA) rose 15.68 percent to close at $23.09 on Thursday.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) climbed 15.11 percent to close at $6.02 on Thursday after gaining 6.30 percent on Wednesday. Baird initiated coverage on Marinus Pharmaceuticals with an Outperform rating.
    Destination Maternity Corporation (NASDAQ: DEST) shares rose 14.48 percent to close at $3.32 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    China Rapid Finance Limited (NYSE: XRF) gained 11.53 percent to close at $3.29 after announcing preliminary Q1 results.
    Bilibili Inc.. (NASDAQ: BILI) shares rose 11.33 pe
  • [By Shane Hupp]

    Get a free copy of the Zacks research report on AcelRx Pharmaceuticals (ACRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58.
    Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009.
    The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613.
    Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65.
    nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results.
    Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303.
    Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    HUYA Inc. (NYSE: HUYA) gained 13.1

Best Casino Stocks To Invest In Right Now: Can-Fite Biopharma Ltd(CANF)

Advisors’ Opinion:

  • [By Shane Hupp]

    Press coverage about Can-Fite Biopharma (NASDAQ:CANF) has trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Can-Fite Biopharma earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.2576556193403 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Lisa Levin] Gainers
    Co-Diagnostics, Inc. (NASDAQ: CODX) jumped 88 percent to $5.4500 after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) climbed 40.3 percent to $5.40 after the company declared a $0.70 per share special dividend.
    Future FinTech Group Inc. (NASDAQ: FTFT) rose 27 percent to $2.73. Future FinTech disclosed a strategic transformation plan including expanding on current blockchain business while also becoming a blockchain incubator, investment and asset management, training, and management consulting.
    SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) gained 14.7 percent to $5.9522 after the company disclosed that its Phase 2b trial of NeuVax in combo with Trastuzumab in HER1+/2+ breast cancer patients met key clinical objectives.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares climbed 14.6 percent to $120.4224 after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    FTE Networks, Inc. (NASDAQ: FTNW) gained 10.5 percent to $20.9399.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 9 percent to $8.07. Leerink Swann upgraded T2 Biosystems from Market Perform to Outperform.
    Zuora, Inc. (NYSE: ZUO) shares rose 8.3 percent to $24.01 after the company reported upbeat Q1 earnings and issued strong outlook.
    VMware, Inc. (NYSE: VMW) rose 7.7 percent to $148.07 as the company reported stronger-than-expected results for its first quarter on Thursday.
    Ambac Financial Group, Inc. (NASDAQ: AMBC) gained 7.5 percent to $19.91. Ambac Financial will replace Integra Lifesciences Holdings in the S&P SmallCap 600 on Tuesday, June 5.
    Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) gained 7 percent to $4.60.
    Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) climbed 6.6 percent to $18.23.
    Franklin Street Properties Corp. (NYSE: FSP) gained 5.7 perce
  • [By Shane Hupp]

    Media headlines about Can-Fite Biopharma (NASDAQ:CANF) have trended positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Can-Fite Biopharma earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 44.6620747072303 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 18.2 percent to $4.55 in pre-market trading after the company declared a $0.70 per share special dividend.
    Co-Diagnostics, Inc. (NASDAQ: CODX) rose 11.7 percent to $3.24 in pre-market trading after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Abercrombie & Fitch Co. (NYSE: ANF) shares rose 8.6 percent to $25.95 in pre-market trading after the company posted upbeat Q1 results.
    Zuora, Inc. (NYSE: ZUO) shares rose 8 percent to $23.95 in pre-market trading after the company reported upbeat Q1 earnings and issued strong outlook.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares rose 7.8 percent to $113.25 in pre-market trading after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    OPKO Health, Inc. (NYSE: OPK) rose 5.7 percent to $4.10 in pre-market trading.
    Lannett Company, Inc. (NYSE: LCI) rose 5.5 percent to $17.45 in pre-market trading following the FDA approval for Levofloxacin Oral Solution.
    Eversource Energy (NYSE: ES) shares rose 5 percent to $59.8 in pre-market trading.
    VMware, Inc. (NYSE: VMW) rose 4.6 percent to $143.74 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Thursday.
    Energy Transfer Partners, L.P. (NYSE: ETP) rose 4.3 percent to $19.80 in pre-market trading after the company reported the Federal Energy Regulatory Commission approval to place Rover pipeline’s full Mainline B into service.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 4.3 percent to $7.73 in pre-market trading after declining 4.26 percent on Thursday.
    Curis, Inc. (NASDAQ: CRIS) rose 4.3 percent to $2.90 in pre-market trading after jumping 21.93 percent on Thursday.
    Sasol Limited (NYSE: SSL) rose 4.2 percent to $37.91 in pre-market trading.
    Nucor Corporatio

Best Casino Stocks To Invest In Right Now: OSI Systems, Inc.(OSIS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Millennium Management LLC lessened its stake in shares of OSI Systems, Inc. (NASDAQ:OSIS) by 40.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 255,483 shares of the technology company’s stock after selling 170,680 shares during the quarter. Millennium Management LLC owned about 1.41% of OSI Systems worth $16,675,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Here are some of the headlines that may have impacted Accern’s rankings:

    Get OSI Systems alerts:

    OSI Systems (OSIS) Rating Increased to Buy at Zacks Investment Research (americanbankingnews.com) OSI Systems (OSIS) Downgraded by BidaskClub (americanbankingnews.com) OSI Systems (OSIS) Downgraded by Zacks Investment Research to Hold (americanbankingnews.com) $274.42 Million in Sales Expected for OSI Systems, Inc. (OSIS) This Quarter (americanbankingnews.com) Zacks: Analysts Expect OSI Systems, Inc. (OSIS) Will Post Earnings of $0.94 Per Share (americanbankingnews.com)

    OSIS has been the subject of several research reports. Sidoti initiated coverage on OSI Systems in a research note on Wednesday, February 21st. They issued a “buy” rating for the company. Zacks Investment Research raised OSI Systems from a “hold” rating to a “buy” rating and set a $69.00 price objective for the company in a research note on Wednesday, April 4th. ValuEngine lowered OSI Systems from a “hold” rating to a “sell” rating in a research note on Wednesday, May 2nd. Jefferies Group lowered OSI Systems from a “buy” rating to a “hold” rating and dropped their price objective for the company from $79.00 to $70.00 in a research note on Friday, February 2nd. They noted that the move was a valuation call. Finally, BidaskClub lowered OSI Systems from a “sell” rating to a “strong sell” rating in a research note on Saturday, January 20th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $86.20.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on OSI Systems (OSIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com